Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1977 Jul;186(1):1–12. doi: 10.1097/00000658-197707000-00001

Current management of melanoma.

H F Seigler, B F Fetter
PMCID: PMC1396200  PMID: 327949

Full text

PDF
1

Images in this article

4Fig. 1.
on p.4
4Fig. 2.
on p.4
4Fig. 3.
on p.4
4Fig. 4.
on p.4
4Fig. 5.
on p.4
4Fig. 6.
on p.4
4Fig. 8.
on p.4
5Fig. 7.
on p.5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Breslow A. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg. 1975 Nov;182(5):572–575. doi: 10.1097/00000658-197511000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown M. M., Sharpe C. A., Macmillan D. S., McGovern V. J. Genetic predisposition to melanoma and other skin cancers in Australians. Med J Aust. 1971 Apr 17;1(16):852–853. doi: 10.5694/j.1326-5377.1971.tb87892.x. [DOI] [PubMed] [Google Scholar]
  3. Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727. [PubMed] [Google Scholar]
  4. Eilber F. R., Morton D. L., Holmes E. C., Sparks F. C., Ramming K. P. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med. 1976 Jan 29;294(5):237–240. doi: 10.1056/NEJM197601292940501. [DOI] [PubMed] [Google Scholar]
  5. GEORGE P. A., FORTNER J. G., PACK G. T. Melanoma with pregnancy. A report of 115 cases. Cancer. 1960 Jul-Aug;13:854–859. doi: 10.1002/1097-0142(196007/08)13:4<854::aid-cncr2820130431>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  6. Ghose T., Norvell S. T., Guclu A., Cameron D., Bodurtha A., MacDonald A. S. Immunochemotherapy of cancer with chlorambucil-carrying antibody. Br Med J. 1972 Aug 26;3(5825):495–499. doi: 10.1136/bmj.3.5825.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gupta R. K., Morton D. L. Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas. Cancer Res. 1975 Jan;35(1):58–62. [PubMed] [Google Scholar]
  8. Gutterman J. U., Mavligit G., Gottlieb J. A., Burgess M. A., McBride C. E., Einhorn L., Freireich E. J., Hersh E. M. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med. 1974 Sep 19;291(12):592–597. doi: 10.1056/NEJM197409192911202. [DOI] [PubMed] [Google Scholar]
  9. Krementz E. T., Ryan R. F. Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience. Ann Surg. 1972 Jun;175(6):900–917. doi: 10.1097/00000658-197206010-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lewis M. G., Johnson K. The incidence and distribution of pigmented naevi in Ugandan Africans. Br J Dermatol. 1968 Jun;80(6):362–366. doi: 10.1111/j.1365-2133.1968.tb12321.x. [DOI] [PubMed] [Google Scholar]
  11. McBride C. M., Sugarbaker E. V., Hickey R. C. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs. Ann Surg. 1975 Sep;182(3):316–324. doi: 10.1097/00000658-197509000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McGOVERN V. J. Melanoblastoma. Med J Aust. 1952 Feb 2;1(5):139–142. doi: 10.5694/j.1326-5377.1952.tb75022.x. [DOI] [PubMed] [Google Scholar]
  13. McGovern V. J. The classification of melanoma and its relationship with prognosis. Pathology. 1970 Apr;2(2):85–98. doi: 10.3109/00313027009077330. [DOI] [PubMed] [Google Scholar]
  14. Minden P., McClatchy J. K., Wainberg M., Weiss D. W. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells. J Natl Cancer Inst. 1974 Nov;53(5):1325–1331. doi: 10.1093/jnci/53.5.1325. [DOI] [PubMed] [Google Scholar]
  15. Moon J. H. Combination chemotherapy in malignant melanoma. Cancer. 1970 Aug;26(2):468–473. doi: 10.1002/1097-0142(197008)26:2<468::aid-cncr2820260231>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  16. Morton D. L., Joseph W. L., Ketcham A. S., Geelhoed G. W., Adkins P. C. Surgical resection and adjunctive immunotherapy for selected patients with multiple pulmonary metastases. Ann Surg. 1973 Sep;178(3):360–366. doi: 10.1097/00000658-197309000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pilch Y. H., Veltman L. L., Kern D. H. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA: implications for immunotherapy. Surgery. 1974 Jul;76(1):23–34. [PubMed] [Google Scholar]
  18. REED W. B., BECKER S. W., Sr, BECKER S. W., Jr, NICKEL W. R. GIANT PIGMENTED NEVI, MELANOMA, AND LEPTOMENINGEAL MELANOCYTOSIS: A CLINICAL AND HISTOPATHOLOGICAL STUDY. Arch Dermatol. 1965 Feb;91:100–119. doi: 10.1001/archderm.1965.01600080008002. [DOI] [PubMed] [Google Scholar]
  19. SPRATT J. S., Jr, SPRATT T. L. RATES OF GROWTH OF PULMONARY METASTASES AND HOST SURVIVAL. Ann Surg. 1964 Feb;159:161–171. doi: 10.1097/00000658-196402000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sadoff L., Winkley J., Tyson S. Is malignant melanoma an endocrine-dependent tumor? The possible adverse effect of estrogen. Oncology. 1973;27(3):244–257. doi: 10.1159/000224736. [DOI] [PubMed] [Google Scholar]
  21. Shiku H., Takahashi T., Oettgen H. F. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med. 1976 Oct 1;144(4):873–881. doi: 10.1084/jem.144.4.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shin H. S., Pasternack G. R., Economou J. S., Johnson R. J., Hayden M. L. Immunotherapy of cancer with antibody. Science. 1976 Oct 15;194(4262):327–329. doi: 10.1126/science.989623. [DOI] [PubMed] [Google Scholar]
  23. Shingleton W. W., Seigler H. F., Stocks L. H., Downs R. W., Jr Management of recurrent melanoma of the extremity. Cancer. 1975 Mar;35(3):574–579. doi: 10.1002/1097-0142(197503)35:3<574::aid-cncr2820350303>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  24. Shiu M. H., Schottenfeld D., Maclean B., Fortner J. G. Adverse effect of pregnancy on melanoma: a reappraisal. Cancer. 1976 Jan;37(1):181–187. doi: 10.1002/1097-0142(197601)37:1<181::aid-cncr2820370126>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  25. Simmons R. L., Rios A. Combined use of BCG and neuraminidase in experimental tumor immunotherapy. Surg Forum. 1971;22:99–101. [PubMed] [Google Scholar]
  26. Stehlin J. S., Jr, Smith J. L., Jr, Jing B. S., Sherrin D. Melanomas of the extremities complicated by in-transit metastases. Surg Gynecol Obstet. 1966 Jan;122(1):3–14. [PubMed] [Google Scholar]
  27. Stuhlmiller G. M., Seigler H. F. Characterization of a chimpanzee anti-human melanoma antiserum. Cancer Res. 1975 Aug;35(8):2132–2137. [PubMed] [Google Scholar]
  28. Stuhlmiller G. M., Seigler H. F. Enzymatic susceptibility and spontaneous release of human melanoma tumor-associated antigens. J Natl Cancer Inst. 1977 Feb;58(2):215–221. doi: 10.1093/jnci/58.2.215. [DOI] [PubMed] [Google Scholar]
  29. Sugarbaker E. V., McBride C. M. Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis. Surgery. 1976 Jul;80(1):22–30. [PubMed] [Google Scholar]
  30. Treves A. J., Cohen I. R., Schechter B., Feldman M. In vivo effects of lymphocytes sensitized in vitro against tumor cells. Ann N Y Acad Sci. 1976;276:165–175. doi: 10.1111/j.1749-6632.1976.tb41644.x. [DOI] [PubMed] [Google Scholar]
  31. Wanebo H. J., Woodruff J., Fortner J. G. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer. 1975 Mar;35(3):666–676. doi: 10.1002/1097-0142(197503)35:3<666::aid-cncr2820350320>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES